Adiponectin, leptin, and yoga practice

Physiology and Behavior

Volumn 107, Issue 5, 2012, Pages 809-813

  Kiecolt Glaser, Janice K ^a   Christian, Lisa M ^a   Andridge, Rebecca ^b   Hwang, Beom Seuk ^a,b   Malarkey, William B ^a,b   Belury, Martha A ^a   Emery, Charles F ^a   Glaser, Ronald ^a,b  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Adiponectin; Complementary medicine; Inflammation; Leptin; Psychoneuroimmunology; Yoga

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; INTERLEUKIN 6; LEPTIN;

ADULT; AGED; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BLOOD SAMPLING; BODY MASS; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; DIET RESTRICTION; DIETARY INTAKE; FEMALE; FITNESS; HEALTH BEHAVIOR; HEALTH HAZARD; HUMAN; HYPERTENSION; INFLAMMATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NORMAL HUMAN; OBESITY; PRIORITY JOURNAL; SELF REPORT; STRESS; YOGA;

ADIPONECTIN; ADULT; AGED; FEMALE; HUMANS; LEPTIN; MIDDLE AGED; QUESTIONNAIRES; YOGA;

EID: 84870725419     PISSN: 00319384     EISSN: 1873507X     Source Type: Journal    
DOI: 10.1016/j.physbeh.2012.01.016     Document Type: Article

References (43)

1. Sabina A.B., Williams A.L., Wall H.K., Bansal S., Chupp G., Katz D.L. Yoga intervention for adults with mild-to-moderate asthma: a pilot study. Ann Allergy Asthma Immunol 2005, 94:543-548.
2. Aljasir B., Bryson M., Al-shehri B. Yoga practice for the management of type II diabetes mellitus in adults: a systematic review. Evid Based Complement Altern Med 2010, 7:399-408.
3. Bower J.E., Garet D., Sternlieb B. Yoga for persistent fatigue in breast cancer survivors: results of a pilot study. Evid Based Complement Altern Med 2011, 2011:623168.
4. Taneja I., Deepak K.K., Poojary G., Acharya I.N., Pandey R.M., Sharma M.P. Yogic versus conventional treatment in diarrhea-predominant irritable bowel syndrome: a randomized control study. Appl Psychophysiol Biofeedback 2004, 29:19-33.
5. Cohen L., Warneke C., Fouladi R.T., Rodriguez M.A., Chaoul-Reich A. Psychological adjustment and sleep quality in a randomized trial of the effects of a Tibetan yoga intervention in patients with lymphoma. Cancer 2004, 100:2253-2260.
6. Vera F.M., Manzaneque J.M., Maldonado E.F., Carranque G.A., Rodriguez F.M., Blanca M.J., et al. Subjective sleep quality and hormonal modulation in long-term yoga practitioners. Biol Psychol 2009, 81:164-168.
7. Khalsa S.B. Treatment of chronic insomnia with yoga: a preliminary study with sleep-wake diaries. Appl Psychophysiol Biofeedback 2004, 29:269-278.
8. Uebelacker L.A., Epstein-Lubow G., Gaudiano B.A., Tremont G., Battle C.L., Miller I.W. Hatha yoga for depression: critical review of the evidence for efficacy, plausible mechanisms of action, and directions for future research. J Psychiatr Pract 2010, 16:22-33.
9. Streeter C.C., Whitfield T.H., Owen L., Rein T., Karri S.K., Yakhkind A., et al. Effects of yoga versus walking on mood, anxiety, and brain GABA levels: a randomized controlled MRS study. J Altern Complement Med 2010, 16:1145-1152.
10. Riley D. Hatha yoga and the treatment of illness. Altern Ther Health Med 2004, 10:20-21.
11. Bernardi L., Sleight P., Bandinelli G., Cencetti S., Fattorini L., Wdowczyc-Szulc J., et al. Effect of rosary prayer and yoga mantras on autonomic cardiovascular rhythms: comparative study. Br Med J 2001, 323:1446-1449.
12. Iyengar B.K.S. Light on yoga 1995, Schocken Books, New York.
13. Kiecolt-Glaser J.K., Christian L., Preston H., Houts C.R., Malarkey W.B., Emery C.F., et al. Stress, inflammation, and yoga practice. Psychosom Med 2010, 72:113-121.
14. Pedersen B.K., Febbraio M.A. Muscle as an endocrine organ: focus on muscle-derived interleukin-6. Physiol Rev 2008, 88:1379-1406.
15. Kiecolt-Glaser J.K., McGuire L., Robles T.R., Glaser R. Emotions, morbidity, and mortality: new perspectives from psychoneuroimmunology. Annu Rev Psychol 2002, 53:83-107.
16. Raison C.L., Capuron L., Miller A.H. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol 2006, 27:24-31.
17. Howren M.B., Lamkin D.M., Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med 2009, 71:171-186.
18. Ouchi N., Parker J.L., Lugus J.J., Walsh K. Adipokines in inflammation and metabolic disease. Nat Rev Immunol 2011, 11:85-97.
19. Taub D.D. Neuroendocrine interactions in the immune system. Cell Immunol 2008, 252:1-6.
20. Dixit V.D., Schaffer E.M., Pyle R.S., Collins G.D., Sakthivel S.K., Palaniappan R., et al. Ghrelin inhibits leptin- and activation-induced proinflammatory cytokine expression by human monocytes and T cells. J Clin Invest 2004, 114:57-66.
21. Tilg H., Moschen A.R. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 2006, 6:772-783.
22. Ble A., Windham B.G., Bandinelli S., Taub D.D., Volpato S., Bartali B., et al. Relation of plasma leptin to C-reactive protein in older adults (from the Invecchiare nel Chianti study). Am J Cardiol 2005, 96:991-995.
23. Koh K.K., Park S.M., Quon M.J. Leptin and cardiovascular disease - response to therapeutic interventions. Circulation 2008, 117:3238-3249.
24. Flanagan D.E., Vaile J.C., Petley G.W., Phillips D.I., Godsland I.F., Owens P., et al. Gender differences in the relationship between leptin, insulin resistance and the autonomic nervous system. Regul Pept 2007, 140:37-42.
25. Simpson K.A., Singh M.A.F. Effects of exercise on adiponectin: a systematic review. Obesity 2008, 16:241-256.
26. Li S., Shin H.J., Ding E.L., van Dam R.M. Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 2009, 302:179-188.
27. Oda N., Iniamura S., Fujita T., Uchida Y., Inagaki K., Kakizawa H., et al. The ratio of leptin to adiponectin can be used as an index of insulin resistance. Metabolism 2008, 57:268-273.
28. Xita N., Papassotiriou I., Georgiou I., Vounatsou M., Margeli A., Tsatsoulis A. The adiponectin-to-leptin ratio in women with polycystic ovary syndrome: relation to insulin resistance and proinflammatory markers. Metabolism 2007, 56:766-771.
29. Lemmink K.A.P.M., Kemper H.C.G., de Greef M.H.G., Rispens P., Stevens M. The validity of the sit-and-reach test and the modified sit-and-reach test in middle-aged to older men and women. Res Q Exerc Sport 2003, 74:331-336.
30. Clasey J.L., Bouchard C., Teates C.D., Riblett J.E., Thorner M.O., Hartman M.L., et al. The use of anthropometric and dual-energy x-ray absorptiometry (DXA) measures to estimate total abdominal and abdominal visceral fat in men and women. Obes Res 1999, 7:256-264.
31. Patterson R.E., Kristal A.R., Carter R.A., Fels-Tinker L.F., Bolton M.P., Argurs-Collins T. Measurement characteristics of women's health initiative food frequency questionnaire. Ann Epidemiol 1999, 9:178-187.
32. Buysse D.J., Reynolds C.F., Monk T.H., Berman S.R., Kupfer D.J. Pittsburgh sleep quality index: a new instrument for psychiatric practice and research. Psychiatry Res 1989, 28:193-213.
33. Watson D., Weber K., Assenheimer J.S., Clark L.A., Strauss M.E., McCormick R.A. Testing a tripartite model: I. Evaluating the convergent and discriminant validity of anxiety and depression symptom scales. J Abnorm Psychol 1995, 104:3-14.
34. Ruth S., Mehrotra S. Differentiating depression and anxiety: psychometric implications of the tripartite model of affect. J Pers Clin Stud 2001, 17:9-18.
35. Matsuzawa Y. White adipose tissue and cardiovascular disease. Best Pract Res Clin Endocrinol Metab 2005, 19:637-647.
36. Wong S.L., DePaoli A.M., Lee J.H., Mantzoros C.S. Leptin hormonal kinetics in the fed state: effects of adiposity, age, and gender on endogenous leptin production and clearance rates. J Clin Endocrinol Metab 2004, 89:2672-2677.
37. Fatouros I.G., Tournis S., Leontsini D., Jamurtas A.Z., Sxina M., Thomakos P., et al. Leptin and adiponectin responses in overweight inactive elderly following resistance training and detraining are intensity related. J Clin Endocrinol Metab 2005, 90:5970-5977.
38. Kasapis C., Thompson P.D. The effects of physical activity on serum C-reactive protein and inflammatory markers: a systematic review. J Am Coll Cardiol 2005, 45:1563-1569.
39. Leo R., Di Lorenzo G., Tesauro M., Cola C., Fortuna E., Zanasi M., et al. Decreased plasma adiponectin concentration in major depression. Neurosci Lett 2006, 407:211-213.
40. Cizza G., Nguyen V.T., Eskandari F., Duan Z., Wright E.C., Reynolds J.C., et al. Low 24-hour adiponectin and high nocturnal leptin concentrations in a case-control study of community-dwelling premenopausal women with major depressive disorder: the premenopausal, osteopenia/osteoporosis, women, alendronate, depression (power) study. J Clin Psychiatry 2010, 71:1079-1087.
41. Pasco J.A., Jacka F.N., Williams L.J., Henry M.J., Nicholson G.C., Kotowicz M.A., et al. Leptin in depressed women: cross-sectional and longitudinal data from an epidemiologic study. J Affect Disord 2008, 107:221-225.
42. Liao S.C., Lee M.B., Lee Y.J., Huang T.S. Hyperleptinemia in subjects with persistent partial posttraumatic stress disorder after a major earthquake. Psychosom Med 2004, 66:23-28.
43. Brennan A.M., Fargnoli J.L., Williams C.J., Li T., Willett W., Kawachi I., et al. Phobic anxiety is associated with higher serum concentrations of adipokines and cytokines in women with diabetes. Diabetes Care 2009, 32:926-931.